Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.37% |
| 2 | Healthcare | 7.45% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.1% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
REFI
4001
Chicago Atlantic Real Estate Finance
REFI
$248M
| $971K | ﹤0.01% |
64,085
-38,771
| -38% | -$563K |
|
4002
Smith & Wesson
SWBI
$651M
| $969K | ﹤0.01% |
74,302
+2,139
| +3% | +$26.1K |
|
4003
CALL
Smith & Nephew
SNN
$13.3B
| $968K | ﹤0.01% |
30,000
-142,900
| -83% | -$4.42M |
|
|
4004
PUT
Smith & Nephew
SNN
$13.3B
| $968K | ﹤0.01% |
+30,000
| New | +$928K |
|
4005
John B. Sanfilippo & Son
JBSS
$967M
| $964K | ﹤0.01% |
8,219
+2,420
| +42% | +$271K |
|
4006
First Capital
FCAP
$212M
| $962K | ﹤0.01% |
31,114
-3,808
| -11% | -$99.2K |
|
4007
CALL
Roku
ROKU
$21.5B
| $959K | ﹤0.01% |
15,000
-9,500
| -39% | -$577K |
|
4008
Phibro Animal Health
PAHC
$1.47B
| $959K | ﹤0.01% |
69,996
+13,364
| +24% | +$191K |
|
4009
PUT
UGI
UGI
$7.74B
| $957K | ﹤0.01% |
+35,500
| New | +$1.08M |
|
4010
Fulgent Genetics
FLGT
$470M
| $956K | ﹤0.01% |
25,807
-25,820
| -50% | -$900K |
|
4011
Ennis
EBF
$552M
| $955K | ﹤0.01% |
46,877
-44,493
| -49% | -$898K |
|
4012
CALL
Newell Brands
NWL
$2.38B
| $955K | ﹤0.01% |
109,800
-630,500
| -85% | -$6.27M |
|
|
4013
CALL
UGI
UGI
$7.74B
| $955K | ﹤0.01% |
+35,400
| New | +$1.07M |
|
4014
Sensient Technologies
SXT
$5.26B
| $953K | ﹤0.01% |
13,394
+10,374
| +344% | +$770K |
|
|
EB
4015
DELISTED
Eventbrite
EB
| $952K | ﹤0.01% |
99,697
-39,469
| -28% | -$310K |
|
4016
Vanguard Health Care ETF
VHT
$18.1B
| $952K | ﹤0.01% |
+3,889
| New | +$946K |
|
|
SSBK
4017
DELISTED
Southern States Bancshares
SSBK
| $950K | ﹤0.01% |
45,038
-53,448
| -54% | -$1.15M |
|
4018
Suncor Energy
SU
$79.4B
| $948K | ﹤0.01% |
32,330
-3,262,904
| -99% | -$97.6M |
|
4019
GoDaddy
GDDY
$11B
| $948K | ﹤0.01% |
12,616
-109,877
| -90% | -$8.11M |
|
|
HSHP
4020
Himalaya Shipping
HSHP
$741M
| $947K | ﹤0.01% |
170,298
-230,618
| -58% | -$1.31M |
|
|
RVNC
4021
CALL
DELISTED
Revance Therapeutics, Inc.
RVNC
| $944K | ﹤0.01% |
+37,300
| New | +$1.16M |
|
4022
Columbus McKinnon
CMCO
$553M
| $944K | ﹤0.01% |
23,220
+10,363
| +81% | +$383K |
|
|
IMGN
4023
PUT
DELISTED
Immunogen Inc
IMGN
| $944K | ﹤0.01% |
50,000
-200,000
| -80% | -$2.36M |
|
|
SWN
4024
PUT
DELISTED
Southwestern Energy Company
SWN
| $941K | ﹤0.01% |
156,500
+79,100
| +102% | +$408K |
|
4025
CALL
ArcelorMittal
MT
$52.9B
| $940K | ﹤0.01% |
34,400
-31,000
| -47% | -$852K |
|
Similar funds
Millennium Management's Q2 2023 Portfolio in Review
As of Q2 2023, Millennium Management held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Millennium Management deployed $14B of net new capital in Q2 2023, opening 869 new positions and adding to 2,214 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, up from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Millennium Management's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Millennium Management added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Millennium Management's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Millennium Management fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Millennium Management's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Millennium Management opened 869 new positions and closed 1,192 in Q2 2023.
- Millennium Management's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.